Monday 8 April 2013

Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018

Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018


Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
 
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.
 

Scope

  • Market size and company share data for Drug Delivery Devices market categories Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. 
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018. 
  • 2011 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Switzerland Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Baxter International Inc., Teleflex Incorporated, B. Braun Melsungen AG and others.
 

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Switzerland Drug Delivery Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution Identify, understand and capitalize.

Companies Covered in this market research report-
  1. GlaxoSmithKline plc 
  2. AstraZeneca PLC 
  3. Boehringer Ingelheim GmbH 
  4. Baxter International Inc. 
  5. Teleflex Incorporated 
  6. B. Braun Melsungen AG 
  7. Medtronic, Inc. 
  8. Hospira, Inc. 
  9. Fresenius Kabi AG 
  10. Terumo Corporation 
  11. Smiths Medical 
  12. Edwards Lifesciences Corporati

No comments:

Post a Comment

Note: only a member of this blog may post a comment.